Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-06-03
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514257, 544295, 544326, A61K 31495, A61K 31505, C07D40304
Patent
active
056355076
ABSTRACT:
A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.
REFERENCES:
patent: 3940393 (1976-02-01), Greenspan et al.
patent: 3980781 (1976-09-01), Snell et al.
patent: 4006235 (1977-02-01), Stickney
patent: 4535080 (1985-08-01), Audiau et al.
patent: 4542136 (1985-09-01), Carminati et al.
patent: 4613603 (1986-09-01), Biziere et al.
patent: 4624952 (1986-11-01), Biziere et al.
patent: 4725600 (1988-02-01), Takaya et al.
patent: 5136080 (1992-08-01), Miller et al.
Allen et al 1980 Naturforsh (B) Anorg 35B (4) 463-467 "Electronic Effects of Aryl and Heteroaryl Groups . . . " I Regnier et a J. Med. Chem. 1972 15, 295-301 Triphenylpropylpiperazine Derivatives as New Potent Analgetic Substances.
Coppola et al 1980 J. Heterocyclic Chem, 17 1479-1482 "Pyrimidones 2. Synthesis of 2-chlorpyrimidines".
Hyde Richard M.
Leach Michael J.
Miller Alistair A.
Nobbs Malcolm S.
Glaxo Wellcome Inc.
Gupta Yogendra N.
LandOfFree
Pharmacologically active CNS compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacologically active CNS compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active CNS compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391881